COVID-19: Identifying high-risk patients in England Mar 23rd 2020, 13.30

• Author: PAPAA
• Topic: Coronavirus (COVID-19)

The British Society for Rheumatology have issued guidance on identifying high-risk patients in England taking immunosuppressive medication.  The guide can be read here

The categories are as follows:

• Definite High risk – to be advised to self-isolate
• Moderate risk – self-isolation only if other concerns or high-risk circumstances
• Low risk –…

NICE to produce rapid COVID-19 guidelines Mar 20th 2020, 15.28

• Author: PAPAA
• Topic: Coronavirus (COVID-19)

NICE is developing a series of rapid guidelines on the active management of COVID-19 infection.

The first 3 guidelines will cover the management of patients in critical care, the management of patients who are having kidney dialysis and the management of patients who are receiving systemic anticancer treatments.

Further guidelines, to be…

Coronavirus (COVID-19) Mar 20th 2020, 14.18

• Author: PAPAA
• Topic: Coronavirus (COVID-19)

There has been some reporting about whether it is safe to take ibuprofen if you have contact with Coronavirus (COVID-19).

Published today the Government response regarding ibuprofen use and Coronavirus (COVID-19) is:

"There is currently no strong evidence that ibuprofen can make Coronavirus (COVID-19) worse."

"Until we have more information,…

Management of rheumatology patients Mar 16th 2020, 15.34

• Author: PAPAA
• Topic: Coronavirus (COVID-19)

Clinical guide for the management of rheumatology patients during the Coronavirus pandemic

This guidance on patients with rheumatological conditions is now on the NHS England website, with more information about risk levels for different conditions and medication.

The guidance puts psoriatic arthritis (PsA) patients in the high (H) increased (I) …